Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Exogenous application of 5-azacitidin, royal jelly and folic acid regulate plant redox state, expression level of DNA methyltransferases and alleviate adverse effects of salinity stress on Vicia faba L. plants. | Heliyon | 2024 | 38784551 | PubTator, text mining | PubMed |
| Autoantibodies against complement proteins in patients with antiphospholipid syndrome: Prevalence and clinical associations. | Eur J Immunol | 2024 | 38700064 | PubTator, text mining | PubMed |
| Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. | Bioact Mater | 2024 | 38699243 | PubTator, text mining | PubMed |
| Platelet-rich fibrin as an autologous biomaterial for bone regeneration: mechanisms, applications, optimization. | Front Bioeng Biotechnol | 2024 | 38689760 | PubTator, text mining | PubMed |
| Methacrylated gelatin and platelet-rich plasma based hydrogels promote regeneration of critical-sized bone defects. | Regen Biomater | 2024 | 38567105 | PubTator, text mining | PubMed |
| Blood Transcriptomics Identifies Multiple Gene Expression Pathways Associated with the Clinical Efficacy of Hymenoptera Venom Immunotherapy. | Int J Mol Sci | 2024 | 38542470 | PubTator, text mining | PubMed |
| Proteomic characteristics of the treatment trajectory of patients with COVID-19. | Arch Virol | 2024 | 38532129 | PubTator, text mining | PubMed |
| Platelet Concentrates Preconditioning of Mesenchymal Stem Cells and Combined Therapies: Integrating Regenerative Strategies for Enhanced Clinical Applications. | Cell Transplant | 2024 | 38506426 | PubTator, text mining | PubMed |
| Sequence-activity mapping via depletion reveals striking mutational tolerance and elucidates functional motifs in Tur1a antimicrobial peptide. | Protein Eng Des Sel | 2024 | 38484121 | PubTator, text mining | PubMed |
| Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis. | J Ovarian Res | 2024 | 38481252 | PubTator, text mining | PubMed |
| Identification of C4BPA as biomarker associated with immune infiltration and prognosis in breast cancer. | Transl Cancer Res | 2024 | 38410217 | PubTator, text mining | PubMed |
| Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection. | Anal Chem | 2024 | 38408370 | PubTator, text mining | PubMed |
| Advances with Platelet-Rich Plasma for Bone Healing. | Biologics | 2024 | 38299120 | PubTator, text mining | PubMed |
| Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. | Int J Mol Sci | 2024 | 38279263 | PubTator, text mining | PubMed |
| Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer's Disease Progression. | Pharmaceuticals (Basel) | 2024 | 38276010 | PubTator, text mining | PubMed |
| Functional Classification and Interaction Selectivity Landscape of the Human SH3 Domain Superfamily. | Cells | 2024 | 38275820 | PubTator, text mining | PubMed |
| The temporal association of CapZ with early endosomes regulates endosomal trafficking and viral entry into host cells. | BMC Biol | 2024 | 38273307 | PubTator, text mining | PubMed |
| PRP as a modulator of inflammation in FLS of RA patients by regulation of galectins and TGF-β1. | Heliyon | 2024 | 38268610 | PubTator, text mining | PubMed |
| The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance. | Mol Diagn Ther | 2024 | 38261250 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression. | Int J Mol Sci | 2024 | 38256011 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=6